Advertisement
News
Advertisement

Alere sees positive results in pre-eclampsia study

Mon, 10/08/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Alere Inc. (NYSE:ALR) has developed a test that can now detect the main cause of pre-eclampsia, a condition when an pregnant women experiences high blood pressure and protein in the urine. The Waltham health-care management company said Monday that results of a UK-based study showed that its Alere Triage blood test, which measures the placental growth factor (PlGF), can quantify risk in women when pre-eclampsia, a condition that can develop during pregnancy, is detected.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading